55 results
Page 3 of 3
424B5
hfcliy82f61os2pzn vu
4 Mar 15
Prospectus supplement for primary offering
12:00am
424B3
zlhnr866dnv
4 Apr 14
Prospectus supplement
12:00am
424B1
rq0cz0y9 vplapa5y1
31 Jan 14
Prospectus with pricing info
12:00am
8-K
qm68sjk5vlt 68
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-14.1
lqofn0jult bw
7 Jan 14
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
424B3
9l7fxds b8e
19 Dec 13
Prospectus supplement
12:00am
8-K
EX-99.1
mmlt0ygtcy6n lq3
9 Dec 13
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia
12:00am
8-K/A
EX-10.1.1
k94nfck951r3ofia5sd5
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
b65ijtk njlbj0
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
rnwo xs7i01439j
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
S-1
8cizsuv
18 Sep 13
IPO registration
12:00am
8-K
EX-10.1.1
by1 3ba6xy62g
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.2
kknd0s0s3q73yul 98xx
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
m6wmdm5
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am